Estudo randomizado com cerca de 30.000 indivíduos mostrou que a vacina Novavax foi segura e teve eficácia geral de 90,4% contra infecções sintomáticas por Covid-19.

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico – New England Journal of Medicine

Comentários:

Novavax COVID vaccine shows 90.4% efficacy against infection – CIDRAP

Novavax COVID-19 vaccine found to be safe and effective – University of Maryland School of Medicine

Conteúdo relacionado: [Preprint] In RCT with 29,949 participants, the Novavax vaccine demonstrated high overall efficacy (>90%) for the prevention of Covid-19, and all moderate-to-severe cases occurred in placebo recipients. (vários artigos sobre o tema)